Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Moderna Drops Ahead of FDA Committee COVID-19 Booster Decision

09/17/2021 | 03:03pm EDT


ę MT Newswires 2021
All news about MODERNA, INC.
11:40aModerna Wins Swiss Regulator's Approval For Booster Dose of COVID-19 Vaccine
MT
11:31aModerna Signs MoU With African Union to Supply Up to 110 Million COVID-19 Vaccine Doses
MT
11:23aCOVID-19 vaccines safe for people with history of severe allergies, study finds
AQ
11:10aSWITZERLAND APPROVES MODERNA COVID B : Bloomberg
MT
10:13aModerna Secures Swiss Regulator's Approval For Booster Dose of COVID-19 Vaccine
MT
09:45aModerna Announces Swissmedic Authorizes Booster Dose of Moderna's COVID-19 Vaccine
BU
09:17aHealth Care Stocks Edge Higher Premarket Tuesday
MT
09:00aModerna to supply Africa with up to 110 million COVID doses
AQ
07:22aAfrican Union to buy up to 110 million Moderna vaccines -officials
RE
05:09aModerna Announces European Medicines Agency's Committee for Medicinal Products for Huma..
AQ
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2021 20 374 M - -
Net income 2021 12 558 M - -
Net cash 2021 13 559 M - -
P/E ratio 2021 11,7x
Yield 2021 -
Capitalization 141 B 141 B -
EV / Sales 2021 6,26x
EV / Sales 2022 5,55x
Nbr of Employees 1 300
Free-Float 90,3%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Last Close Price 349,56 $
Average target price 295,79 $
Spread / Average Target -15,4%
EPS Revisions
Managers and Directors
StÚphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.234.60%141 099
LONZA GROUP AG31.93%60 646
IQVIA HOLDINGS INC.43.58%49 145
SEAGEN INC.0.22%31 933
CELLTRION, INC.-39.69%25 328
ALNYLAM PHARMACEUTICALS, INC.53.63%23 730